Intralesional Gardasil-9 for the Treatment of Recalcitrant Warts
Intralesional Gardasil-9 for the Treatment of Recalcitrant Warts
Active, not recruiting · NCT07806617 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intralesional Gardasil-9 for the Treatment of Recalcitrant Warts | DNA Virus Infections, Infections, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, common wart, human papilloma virus infection, skin disorder, skin disorder caused by infection, viral infectious disease | Active, not recruiting | Phase 2 | 2026-09-15 | NCT07806617 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Rush University Department of Dermatology | 1 |
| Rush University Medical Center | 106 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Rush University Medical Center | Chicago | United States | 283 |